ArticleThe oncologist2024

Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in China.

Ying Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.